Key Events This Week
21 Sep: New 52-week and all-time high at Rs.1,992.95 and Rs.1,986.35
22 Sep: Stock surged to Rs.2,032.50, setting fresh 52-week and all-time highs
23 Sep: Continued momentum with new high at Rs.2,032.60
24 Sep: Reached Rs.2,050, marking another 52-week and all-time high
25 Sep: Week closed at Rs.2,001.00, a slight pullback amid volatile market
Monday, 21 September 2026: Breakthrough to New Highs
Laurus Labs began the week on a strong note, hitting a new 52-week high of Rs.1,992.95 and an all-time high of Rs.1,986.35. The stock closed at Rs.2,018.00, up 3.21%, significantly outperforming the Sensex’s 0.46% gain. This surge was driven by the company’s impressive quarterly results, including a 124.73% net profit growth and a robust return on capital employed of 15.19%. Institutional investors increased their stake, reflecting confidence in the company’s fundamentals. Technical indicators such as MACD and Bollinger Bands supported the bullish momentum, with the stock trading comfortably above all key moving averages.
Tuesday, 22 September 2026: Sustained Momentum Amid Mixed Market
On 22 September, Laurus Labs extended its rally, touching a new 52-week and all-time high of Rs.2,032.50. Despite a slight daily decline of 0.64% to Rs.2,005.10, the stock maintained strength relative to the Sensex, which fell 0.32%. The company’s consistent earnings growth and efficient capital utilisation continued to underpin investor interest. Delivery volumes surged, indicating active participation. The stock’s valuation remained premium but was supported by a PEG ratio of 0.9, suggesting reasonable alignment between price and earnings growth.
Fundamentals that don't lie! This Small Cap from Trading shows consistent growth and price strength over time. A reliable pick you can truly count on.
- - Strong fundamental track record
- - Consistent growth trajectory
- - Reliable price strength
Wednesday, 23 September 2026: New Highs Amid Positive Market Sentiment
The stock regained upward momentum on 23 September, closing at Rs.2,034.80, a 1.48% gain that outpaced the Sensex’s 0.56% rise. Laurus Labs hit a new 52-week and all-time high of Rs.2,032.60, supported by strong institutional buying and positive technical signals. The company’s seven consecutive quarters of profit growth and a high operating profit to interest ratio of 15.12 times reinforced investor confidence. Despite a bearish weekly RSI, other indicators such as MACD and KST remained bullish, signalling sustained strength.
Thursday, 24 September 2026: Peak at Rs.2,050 Amid Market Weakness
On 24 September, Laurus Labs reached its highest level of the week at Rs.2,050, marking another 52-week and all-time high. This came despite a weak broader market, with the Sensex falling 0.89%. The stock outperformed its sector by 0.46%, reflecting resilience amid market headwinds. Financial metrics remained robust, with a half-year ROCE of 17.30% and record operating cash flow of Rs.1,623.50 crores. Delivery volumes surged, indicating strong investor participation. The stock’s premium valuation was balanced by solid earnings growth and institutional support.
Thinking about Laurus Labs Ltd? Our real-time Verdict report breaks down everything – from financial health and peer comparison to technical signals and fair valuation for this mid-cap stock!
- - Real-time Verdict available
- - Financial health breakdown
- - Fair valuation calculated
Friday, 25 September 2026: Slight Pullback Amid Volatility
The week concluded with a modest decline of 1.25% to Rs.2,001.00, as the stock faced profit-taking amid volatile market conditions. The Sensex, however, posted a small gain of 0.18%. Despite the pullback, Laurus Labs maintained a weekly gain of 2.34%, reflecting overall strength. The stock remains well supported above key moving averages, with institutional investors holding a significant 41.74% stake. Valuation metrics remain elevated, but the company’s consistent earnings growth and operational efficiency continue to justify the premium.
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-09-21 | Rs.2,018.00 | +3.21% | 35,787.64 | +0.46% |
| 2026-09-22 | Rs.2,005.10 | -0.64% | 35,672.04 | -0.32% |
| 2026-09-23 | Rs.2,034.80 | +1.48% | 35,870.78 | +0.56% |
| 2026-09-24 | Rs.2,026.25 | -0.42% | 35,291.38 | -1.62% |
| 2026-09-25 | Rs.2,001.00 | -1.25% | 35,353.29 | +0.18% |
Key Takeaways from the Week
Strong Earnings Drive Momentum: Laurus Labs’ exceptional quarterly results, including a 124.73% net profit increase and a high operating profit margin of 31.50%, were pivotal in driving the stock’s rally.
Institutional Confidence: With 41.74% institutional ownership and a 1.95% increase in holdings, the stock benefits from strong backing by well-informed investors.
Technical Strength: The stock consistently traded above all major moving averages, supported by bullish MACD, Bollinger Bands, and KST indicators, despite some short-term RSI caution.
Valuation Premium: Laurus Labs trades at elevated multiples, including a P/E near 100 and EV/EBITDA above 50, reflecting market expectations for sustained performance but warranting careful monitoring.
Market Outperformance: The stock outperformed the Sensex by over 3% during the week, highlighting its resilience amid broader market volatility and sector challenges.
Conclusion
Laurus Labs Ltd’s performance during the week of 21 to 25 September 2026 underscores its position as a strong mid-cap player in the Pharmaceuticals & Biotechnology sector. The stock’s ability to hit multiple new highs amid a volatile market reflects robust fundamentals, efficient capital utilisation, and sustained institutional support. While valuation metrics remain on the higher side, the company’s consistent earnings growth and positive technical outlook provide a solid foundation for its current market standing. Investors should continue to monitor the balance between premium valuation and operational performance as the stock navigates near-term volatility.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
